Sale!

KIF23 Gene Dyserythropoietic Anemia Congenital Type 3 NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The KIF23 Gene Dyserythropoietic Anemia Congenital Type 3 NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the KIF23 gene responsible for congenital dyserythropoietic anemia type 3. This comprehensive genetic analysis utilizes next-generation sequencing technology to detect specific genetic variations that cause abnormal red blood cell production and maturation. The test provides crucial information for patients experiencing unexplained anemia, abnormal blood cell morphology, or family history of blood disorders. Results help guide personalized treatment strategies and inform family planning decisions. Available for only $500 USD, this test offers significant savings from the regular $700 price. Our nationwide network of testing centers ensures convenient access across major US cities.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

KIF23 Gene Dyserythropoietic Anemia Congenital Type 3 NGS Genetic DNA Test

Comprehensive Genetic Testing for Inherited Blood Disorders

The KIF23 Gene Dyserythropoietic Anemia Congenital Type 3 NGS Genetic DNA Test represents a breakthrough in molecular diagnostics for inherited hematological conditions. This advanced genetic analysis specifically targets mutations in the KIF23 gene, which plays a critical role in proper red blood cell development and maturation. Congenital dyserythropoietic anemia type 3 is a rare inherited disorder characterized by ineffective erythropoiesis, leading to chronic anemia and potential complications throughout life.

What Does This Test Measure and Detect?

Our comprehensive NGS-based genetic test specifically identifies:

  • Pathogenic variants in the KIF23 gene associated with congenital dyserythropoietic anemia type 3
  • Single nucleotide polymorphisms (SNPs) affecting red blood cell production
  • Insertions, deletions, and missense mutations impacting erythropoiesis
  • Genetic markers that influence disease severity and progression
  • Inheritance patterns for family genetic counseling purposes

Who Should Consider This Genetic Test?

This specialized genetic testing is recommended for individuals experiencing:

  • Unexplained chronic anemia that doesn’t respond to conventional treatments
  • Family history of congenital dyserythropoietic anemia or inherited blood disorders
  • Abnormal red blood cell morphology observed in peripheral blood smears
  • Persistent fatigue, weakness, or pallor without clear underlying cause
  • Children with developmental delays and hematological abnormalities
  • Individuals planning pregnancy with family history of blood disorders

Clinical Benefits of KIF23 Genetic Testing

Undergoing this comprehensive genetic analysis provides numerous clinical advantages:

  • Accurate Diagnosis: Precise identification of the specific genetic mutation causing dyserythropoietic anemia
  • Personalized Treatment: Tailored therapeutic approaches based on genetic findings
  • Family Planning Guidance: Essential information for genetic counseling and reproductive decisions
  • Early Intervention: Opportunity for proactive management before complications develop
  • Disease Monitoring: Baseline genetic information for tracking disease progression
  • Research Contribution: Participation in advancing understanding of rare hematological disorders

Understanding Your Test Results

Our comprehensive genetic report provides clear, actionable information:

  • Positive Result: Indicates the presence of pathogenic KIF23 gene mutations, confirming congenital dyserythropoietic anemia type 3 diagnosis
  • Negative Result: Suggests absence of known disease-causing mutations in the KIF23 gene
  • Variant of Uncertain Significance: Identifies genetic changes with unknown clinical impact requiring further evaluation
  • Carrier Status: Determines if individuals carry one copy of a mutated gene without showing symptoms

All results include detailed interpretation by our board-certified genetic counselors and hematologists, ensuring you receive comprehensive guidance for next steps.

Test Pricing and Availability

Test Name Discount Price Regular Price
KIF23 Gene Dyserythropoietic Anemia Congenital Type 3 NGS Genetic DNA Test $500 USD $700 USD

Nationwide Testing Accessibility

We maintain comprehensive testing facilities across the United States, with convenient locations in:

  • New York City and surrounding metropolitan areas
  • Los Angeles and Southern California regions
  • Chicago and Midwest territories
  • Houston and Texas medical centers
  • Phoenix and Southwest facilities
  • Philadelphia and Northeast locations
  • And many additional major cities nationwide

Take Control of Your Genetic Health Today

Don’t let uncertainty about inherited blood disorders impact your quality of life. Our KIF23 Gene Dyserythropoietic Anemia Congenital Type 3 NGS Genetic DNA Test provides the clarity and confidence you need for informed healthcare decisions. With results available in 3-4 weeks and sample collection options including blood, extracted DNA, or FTA card blood drops, getting tested has never been more convenient.

Call us now at +1(267) 388-9828 to schedule your genetic counseling session and book your test. Our dedicated genetic specialists are ready to guide you through every step of the process and help you understand your genetic health.

Remember to bring your clinical history and be prepared for a comprehensive genetic counseling session to create a detailed family pedigree chart. This essential pre-test preparation ensures the most accurate and meaningful results for your specific situation.